DEA is revising the definition of THC and marijuana extracts under the Controlled Substances Act (CSA) to exclude substances that are considered legal hemp (containing no more than 0.3 percent THC).
It is also making it so any CBD-based drugs approved by the Food and Drug Administration (FDA) are removed from Schedule V.
Finally, the proposed regulations remove restrictions on importing and exporting hemp and its derivatives.